{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:25:15Z","timestamp":1774563915204,"version":"3.50.1"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The HIV-1 pandemic is a significant challenge to the field of medicine. Despite advancements in antiretroviral (ART) development, 38 million people worldwide still live with this disease without a cure. A significant barrier to the eradication of HIV-1 lies in the persistently latent pool that establishes early in the infection. The \u201cshock and kill\u201d strategy relies on the discovery of a latency-reversing agent (LRA) that can robustly reactivate the latent pool and not limit immune clearance. We have found that a benzodiazepine (BDZ), that is commonly prescribed for panic and anxiety disorder, to be an ideal candidate for latency reversal. The BDZ Alprazolam functions as an inhibitor of the transcription factor RUNX1, which negatively regulates HIV-1 transcription. In addition to the displacement of RUNX1 from the HIV-1 5\u2032LTR, Alprazolam potentiates the activation of STAT5 and its recruitment to the viral promoter. The activation of STAT5 in cytotoxic T cells may enable immune activation which is independent of the IL-2 receptor. These findings have significance for the potential use of Alprazolam in a curative strategy and to addressing the neuroinflammation associated with neuroHIV-1.<\/jats:p>","DOI":"10.3389\/fneur.2021.663793","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T07:46:57Z","timestamp":1626940017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Alprazolam Prompts HIV-1 Transcriptional Reactivation and Enhances CTL Response Through RUNX1 Inhibition and STAT5 Activation"],"prefix":"10.3389","volume":"12","author":[{"given":"Angel","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weam Othman","family":"Elbezanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Schirling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Van Duyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Cocklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Klase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"B1","volume-title":"Global HIV-1 & AIDS Statistics \u2014 2020 Fact Sheet","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less","volume":"337","author":"Hammer","year":"1997","journal-title":"New Eng J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.virol.2014.02.008","article-title":"Transcriptional control of HIV-1 latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure","author":"Mbonye","year":"2014","journal-title":"Virology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/COH.0b013e328340ffbb","article-title":"The molecular biology of HIV-1 latency: breaking and restoring the Tat-dependent transcriptional circuit","volume":"4","author":"Karn","year":"2011","journal-title":"Curr Opin HIV AIDS."},{"key":"B5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy","volume":"18","author":"Pierson","year":"2000","journal-title":"Ann Rev Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3390\/v12050555","article-title":"HIV-1-1 proviral transcription and latency in the new era","volume":"12","author":"Shukla","year":"2020","journal-title":"Viruses."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1172\/JCI136227","article-title":"The multifaceted nature of HIV-1 latency","volume":"130","author":"Dufour","year":"2020","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"aaf6517","DOI":"10.1126\/science.aaf6517","article-title":"Latency reversal and viral clearance to cure HIV-1-1","volume":"353","author":"Margolis","year":"2016","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrmicro3352","article-title":"Eradicating HIV-1-1 infection: seeking to clear a persistent pathogen","volume":"12","author":"Archin","year":"2014","journal-title":"Nat Rev Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cell.2020.03.005","article-title":"Curing HIV-1: seeking to target and clear persistent infection","volume":"181","author":"Margolis","year":"2020","journal-title":"Cell."},{"key":"B12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molmed.2015.11.004","article-title":"HIV-1-1 eradication: early trials (and tribulations)","volume":"22","author":"Spivak","year":"2016","journal-title":"Trend Mol Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-981-13-0484-2_12","article-title":"Clinical interventions in HIV-1 cure research","volume":"1075","author":"Rasmussen","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3389\/fmicb.2019.03060","article-title":"Current status of latency reversing agents facing the heterogeneity of HIV-1-1 cellular and tissue reservoirs","volume":"10","author":"Ait-Ammar","year":"2019","journal-title":"Front Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e1004287","DOI":"10.1371\/journal.ppat.1004287","article-title":"Histone deacetylase inhibitors impair the elimination of HIV-1-infected cells by cytotoxic T-Lymphocytes","volume":"10","author":"Jones","year":"2014","journal-title":"PLoS Pathog."},{"key":"B16","doi-asserted-by":"publisher","first-page":"579158","DOI":"10.3389\/fimmu.2020.579158","article-title":"Pharmacokinetics and immunological effects of romidepsin in rhesus macaques","volume":"11","author":"Kleinman","year":"2020","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fimmu.2020.00418","article-title":"In vivo effects of romidepsin on T-Cell activation, apoptosis and function in the BCN02 HIV-1-1 Kick&Kill clinical trial","volume":"11","author":"Rosas-Umbert","year":"2020","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1065-6995(03)00018-0","article-title":"Runx transcription factors and the developmental balance between cell proliferation and differentiation","volume":"27","author":"Coffman","year":"2003","journal-title":"Cell Biol Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"dev148296","DOI":"10.1242\/dev.148296","article-title":"RUNX transcription factors: orchestrators of development","volume":"146","author":"Mevel","year":"2019","journal-title":"Development."},{"key":"B20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1615\/CritRevEukarGeneExpr.v15.i3.20","article-title":"Biological implications of filamin A-bound PEBP2beta\/CBFbeta retention in the cytoplasm","volume":"15","author":"Watanabe","year":"2005","journal-title":"Crit Rev Eukaryot Gene Expr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/blood-2008-11-191890","article-title":"Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program","volume":"114","author":"Hoogenkamp","year":"2009","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ng.2007.7","article-title":"PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis","volume":"40","author":"Huang","year":"2008","journal-title":"Nat Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1038\/emboj.2012.275","article-title":"RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis","volume":"31","author":"Lichtinger","year":"2012","journal-title":"EMBO J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1074\/jbc.M110.149013","article-title":"Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3","volume":"286","author":"Guo","year":"2011","journal-title":"J Biol Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1038\/sj.onc.1209591","article-title":"RUNX1 associates with histone deacetylases and SUV39H1 to repress transcription","volume":"25","author":"Reed-Inderbitzin","year":"2006","journal-title":"Oncogene."},{"key":"B26","doi-asserted-by":"publisher","first-page":"10675","DOI":"10.1128\/MCB.25.24.10675-10683.2005","article-title":"Runx1 binds positive transcription elongation factor b and represses transcriptional elongation by RNA polymerase II: possible mechanism of CD4 silencing","volume":"25","author":"Jiang","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jcb.22142","article-title":"Megakaryocytic programming by a transcriptional regulatory loop: a circle connecting RUNX1, GATA-1, and P-TEFb","volume":"107","author":"Goldfarb","year":"2009","journal-title":"J Cell Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1128\/MCB.00909-07","article-title":"Differential chromatin looping regulates CD4 expression in immature thymocytes","volume":"28","author":"Jiang","year":"2008","journal-title":"Mol Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1003997","DOI":"10.1371\/journal.ppat.1003997","article-title":"Activation of HIV-1-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA","volume":"10","author":"Klase","year":"2014","journal-title":"PLoS Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/v12020191","article-title":"Benzodiazepines drive alteration of chromatin at the integrated HIV-1-1 LTViruses R","volume":"12","author":"Elbezanti","year":"2020"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1126\/science.1763331","article-title":"Inhibition of HIV-1 replication in acute and chronic infections in vitro by a Tat antagonist","volume":"254","author":"Hsu","year":"1991","journal-title":"Science."},{"key":"B32","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1602\/neurorx.2.4.554","article-title":"Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery","volume":"2","author":"Alavijeh","year":"2005","journal-title":"NeuroRx."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e01186","DOI":"10.1128\/mBio.01186-17","article-title":"Brain macrophages in simian immunodeficiency virus-infected, antiretroviral-suppressed macaques: a functional latent reservoir","volume":"8","author":"Avalos","year":"2017","journal-title":"Mbio."},{"key":"B35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13365-018-0616-6","article-title":"An SIV macaque model of SIV and HAND: the need for adjunctive therapies in HIV-1 that target activated monocytes and macrophages","volume":"24","author":"Mallard","year":"2018","journal-title":"J Neurovirol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s13365-015-0346-y","article-title":"Role of the macrophage in HIV-1-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment","volume":"21","author":"Rappaport","year":"2015","journal-title":"J Neurovirol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ana.410190603","article-title":"The AIDS dementia complex: II. Neuropathology","volume":"19","author":"Navia","year":"1986","journal-title":"Ann Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.20411\/pai.v2i2.204","article-title":"HIV-1 infection of macrophages: implications for pathogenesis and cure","volume":"2","author":"Clayton","year":"2017","journal-title":"Pathog Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s11481-009-9174-2","article-title":"CNS inflammation and macrophage\/microglial biology associated with HIV-1-1 infection","volume":"4","author":"Yadav","year":"2009","journal-title":"J Neuroimmune Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(02)00207-1","article-title":"The role of macrophage\/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-1-associated dementia, Alzheimer disease, multiple sclerosis","volume":"202","author":"Minagar","year":"2002","journal-title":"J Neurol Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e69270","DOI":"10.1371\/journal.pone.0069270","article-title":"Mechanisms of HIV-1 entry into the CNS: increased sensitivity of HIV-1 infected CD14(+)CD16(+) monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in Diapedesis","volume":"8","author":"Williams","year":"2013","journal-title":"PLoS ONE."},{"key":"B42","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1189\/jlb.0503204","article-title":"The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV-1 infection","volume":"74","author":"Crowe","year":"2003","journal-title":"J Leukoc Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s13365-014-0287-x","article-title":"HIV-1-1 target cells in the CNS","volume":"21","author":"Joseph","year":"2015","journal-title":"J Neurovirol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-1-associated neurocognitive disorder - pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/QAD.0000000000001796","article-title":"Global HIV-1 neurology: a comprehensive review","volume":"33","author":"Thakur","year":"2019","journal-title":"AIDS."},{"key":"B46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1742-4690-11-35","article-title":"Rapid inflammasome activation in microglia contributes to brain disease in HIV-1\/AID","volume":"11","author":"Walsh","year":"2014","journal-title":"Retrovirology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/QAD.0000000000001858","article-title":"Microglial activation is inversely associated with cognition in individuals living with HIV-1 on effective antiretroviral therapy","volume":"32","author":"Rubin","year":"2018","journal-title":"AIDS."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1097\/QAD.0000000000001950","article-title":"Persistent central nervous system immune activation following more than 10 years of effective HIV-1 antiretroviral treatment","volume":"32","author":"Ulfhammer","year":"2018","journal-title":"AIDS."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/01.wnr.0000176516.19347.6f","article-title":"Prolactin-induced activation of STAT5 within the hypothalamic arcuate nucleus","volume":"16","author":"Cave","year":"2005","journal-title":"Neuroreport."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1210\/en.2005-0770","article-title":"Prolactin specifically activates signal transducer and activator of transcription 5b in neuroendocrine dopaminergic neurons","volume":"146","author":"Ma","year":"2005","journal-title":"Endocrinology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2826.2005.01296.x","article-title":"Hypothalamic STAT proteins: regulation of somatostatin neurones by growth hormone via STAT5b","volume":"17","author":"Bennett","year":"2005","journal-title":"J Neuroendocrinol."},{"key":"B52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4049\/jimmunol.160.1.28","article-title":"HIV-1-1 infection induces a selective reduction in STAT5 protein expression","volume":"160","author":"Pericle","year":"1998","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00002030-200003100-00012","article-title":"Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV-1 disease: effect on infections, CD4 cell counts and HIV-1 suppression. Leukine\/HIV-1 Study Group","volume":"14","author":"Angel","year":"2000","journal-title":"AIDS."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1001\/jama.284.17.2193","article-title":"Evaluation of HIV-1-1 immunogen, an immunologic modifier, administered to patients infected with HIV-1 having 300 to 549 \u00d7 10(6)\/L CD4 cell counts: A randomized controlled trial","volume":"284","author":"Kahn","year":"2000","journal-title":"JAMA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1126\/science.3131876","article-title":"Interleukin-2: inception, impact, and implications","volume":"240","author":"Smith","year":"1988","journal-title":"Science."},{"key":"B56","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"9380","DOI":"10.1073\/pnas.142287999","article-title":"HIV-1 envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication","volume":"99","author":"Cicala","year":"2002","journal-title":"Proc Nat Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"JAKS AND STATS: biological implications","volume":"16","author":"Leonard","year":"1998","journal-title":"Ann Rev Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0955-0674(97)80067-1","article-title":"The state of the STATs: recent developments in the study of signal transduction to the nucleus","volume":"9","author":"Horvath","year":"1997","journal-title":"Curr Opin Cell Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1182\/blood.V98.9.2752","article-title":"HIV-1-1 Nef activates STAT1 in human monocytes\/macrophages through the release of soluble factors","volume":"98","author":"Federico","year":"2001","journal-title":"Blood."},{"key":"B61","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1182\/blood-2006-08-042556","article-title":"Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1-1 expression","volume":"109","author":"Crotti","year":"2007","journal-title":"Blood."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.jmb.2014.07.020","article-title":"A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions","volume":"427","author":"Shiina","year":"2015","journal-title":"J Mol Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0022-2836(02)00702-7","article-title":"The RUNX1 runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding","volume":"322","author":"Backstrom","year":"2002","journal-title":"J Mol Biol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.molcel.2012.12.012","article-title":"CBF\u03b2 stabilizes HIV-1 Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression","volume":"49","author":"Kim","year":"2013","journal-title":"Molecular Cell."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1500296","DOI":"10.1126\/sciadv.1500296","article-title":"Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-\u03b2\/RUNX axis","volume":"1","author":"Anderson","year":"2015","journal-title":"Sci Adv."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1128\/MCB.16.7.3967","article-title":"The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability","volume":"16","author":"Tanaka","year":"1996","journal-title":"Mol Cell Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ni1424","article-title":"Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells","volume":"8","author":"Djuretic","year":"2007","journal-title":"Nat Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature05673","article-title":"Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1","volume":"446","author":"Ono","year":"2007","journal-title":"Nature."},{"key":"B69","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1073\/pnas.1315023111","article-title":"NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Nat Acad Sci USA."},{"key":"B70","doi-asserted-by":"publisher","first-page":"11110","DOI":"10.1074\/jbc.M110.166694","article-title":"Down-regulation of Runx1 expression by TCR signal involves an autoregulatory mechanism and contributes to IL-2 production","volume":"286","author":"Wong","year":"2011","journal-title":"J Biol Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/ni.1663","article-title":"Interactions among the transcription factors Runx1, ROR\u03b3t and Foxp3 regulate the differentiation of interleukin 17\u2013producing T cells","volume":"9","author":"Zhang","year":"2008","journal-title":"Nat Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-2567.2010.03381.x","article-title":"Interplay of transcription factors in T-cell differentiation and function: the role of Runx","volume":"132","author":"Wong","year":"2011","journal-title":"Immunology."},{"key":"B73","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/jb\/mvn022","article-title":"Physical and functional interactions between STAT5 and Runx transcription factors","volume":"143","author":"Ogawa","year":"2008","journal-title":"J Biochem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1182\/bloodadvances.2018021063","article-title":"STAT5 is essential for IL-7\u2013mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells","volume":"2","author":"Ribeiro","year":"2018","journal-title":"Blood Adv."},{"key":"B75","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1128\/JVI.73.1.797-800.1999","article-title":"Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy","volume":"73","author":"Ogg","year":"1999","journal-title":"J Virol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/COH.0b013e328361eaca","article-title":"HIV-1-1 eradication strategies: design and assessment","volume":"8","author":"Siliciano","year":"2013","journal-title":"Curr Opin HIV-1 AIDS."},{"key":"B77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ebiom.2016.04.019","article-title":"The effect of latency reversal agents on primary CD8+ T cells: implications for shock and kill strategies for human immunodeficiency virus eradication","volume":"8","author":"Walker-Sperling","year":"2016","journal-title":"EBio Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"Michael: CD8+ T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1128\/jvi.71.4.3120-3128.1997","article-title":"Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms","volume":"71","author":"Yang","year":"1997","journal-title":"J Virol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: a lesson in detente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Science."},{"key":"B81","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00002030-200402200-00007","article-title":"Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-1-positive patients: restoration by antiretroviral therapy","volume":"18","author":"Kryworuchko","year":"2004","journal-title":"AIDS."},{"key":"B82","doi-asserted-by":"publisher","first-page":"16601","DOI":"10.1073\/pnas.1003457107","article-title":"Differential effects of STAT5 and PI3K\/AKT signaling on effector and memory CD8 T-cell survival","volume":"107","author":"Hand","year":"2010","journal-title":"Proc Nat Acad Sci USA."},{"key":"B83","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/00002030-200303070-00007","article-title":"Impaired production of cytokines is an independent predictor of mortality in HIV-1-1-infected patients","volume":"17","author":"Ostrowski","year":"2003","journal-title":"AIDS."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/0024-3205(90)90485-A","article-title":"Immunoenhancing effects of alprazolam in mice","volume":"47","author":"Fride","year":"1990","journal-title":"Life Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3109\/08923978609026493","article-title":"Effect of benzodiazepine derivatives: I. Augmentation of T cell-dependent antibody response by diazepam in mouse spleen cells","volume":"8","author":"Okimura","year":"1986","journal-title":"J Immunopharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0091-3057(92)90642-S","article-title":"Effects of midazolam on T-cell immunosuppressive response to surgical stress in mice","volume":"43","author":"Freire-Garabal","year":"1992","journal-title":"Pharmacol Biochem Behav."},{"key":"B87","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0304-3835(91)90098-3","article-title":"Effects of alprazolam on T-cell immunosuppressive response to surgical stress in mice","volume":"58","author":"Freire-Garabal","year":"1991","journal-title":"Cancer Lett."},{"key":"B88","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1189\/jlb.0306154","article-title":"Type I interferon production in HIV-1-infected patients","volume":"80","author":"Hosmalin","year":"2006","journal-title":"J Leuk Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/08923979309035237","article-title":"In vivo effects of alprazolam and lorazepam on the immune response in patients with migraine without aura","volume":"15","author":"Covelli","year":"1993","journal-title":"Immunopharmacol Immunotoxicol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e974959","DOI":"10.4161\/2162402X.2014.974959","article-title":"IFNgamma producing CD8(+) T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas","volume":"4","author":"Buferne","year":"2015","journal-title":"Oncoimmunology."},{"key":"B91","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jcrc.2020.12.017","article-title":"Neuroinflammation, neuronal damage or cognitive impairment associated with mechanical ventilation: a systematic review of evidence from animal studies","volume":"62","author":"Giordano","year":"2020","journal-title":"J Crit Care."},{"key":"B92","doi-asserted-by":"publisher","first-page":"612439","DOI":"10.3389\/fnmol.2020.612439","article-title":"Neuroinflammation in ischemic stroke: focus on MicroRNA-mediated polarization of microglia","volume":"13","author":"Lian","year":"2020","journal-title":"Front Mol Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tins.2020.10.008","article-title":"Signaling by cGAS-STING in neurodegeneration, neuroinflammation, and aging","volume":"44","author":"Paul","year":"2021","journal-title":"Trends Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/cells9081857","article-title":"Role of inflammasomes in HIV-1-1 and drug abuse mediated neuroinflammaging","volume":"9","author":"Sil","year":"2020","journal-title":"Cells."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1007\/s12035-021-02288-y","article-title":"Emerging role of microglia-mediated neuroinflammation in epilepsy after subarachnoid hemorrhage","volume":"58","author":"Wang","year":"2021","journal-title":"Mol Neurobiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.pneurobio.2006.10.002","article-title":"The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging","volume":"80","author":"Venneti","year":"2006","journal-title":"Prog Neurobiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"465726","DOI":"10.1155\/2015\/465726","article-title":"Benzodiazepines and Z-drug use among HIV-1-infected patients in Taiwan: a 13-year nationwide cohort study","volume":"2015","author":"Wei","year":"2015","journal-title":"Biomed Res Int."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1080\/09540121.2014.894615","article-title":"Sex differences in benzodiazepine use in the HIV-1-infected population","volume":"26","author":"Wixson","year":"2014","journal-title":"AIDS Care."},{"key":"B99","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0376-8716(93)90047-T","article-title":"Drug use, HIV-1 risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients","volume":"34","author":"Drake","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"B100","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2015.07.017","article-title":"Benzodiazepine use as an independent risk factor for HIV-1 infection in a Canadian setting","volume":"155","author":"Ickowicz","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"B101","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","article-title":"Benzodiazepine use, misuse, and abuse: a review","volume":"6","author":"Schmitz","year":"2016","journal-title":"Ment Health Clin."},{"key":"B102","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00124499","article-title":"Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4","volume":"10","author":"Morris","year":"1996","journal-title":"J Comput Aided Mol Des."},{"key":"B103","doi-asserted-by":"publisher","first-page":"8.14.1","DOI":"10.1002\/0471250953.bi0814s24","article-title":"Using AutoDock for ligand-receptor docking","volume":"24","author":"Morris","year":"2008","journal-title":"Curr Protoc Bioinformatics"},{"key":"B104","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1074\/jbc.M110.196493","article-title":"Expression of a protein phosphatase 1 inhibitor, cdNIPP1, increases CDK9 threonine 186 phosphorylation and inhibits HIV-1-1 transcription","volume":"286","author":"Ammosova","year":"2011","journal-title":"J Biol Chem."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1128\/JVI.73.2.1331-1340.1999","article-title":"Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site","volume":"73","author":"Verhoef","year":"1999","journal-title":"J Virol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.663793\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:08:10Z","timestamp":1672895290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.663793\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":105,"alternative-id":["10.3389\/fneur.2021.663793"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.663793","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"article-number":"663793"}}